Ventilator-Associated Events: Prevalence, Outcome, and Relationship with Ventilator-Associated Pneumonia

Critical Care Medicine

Volumn 43, Issue 9, 2015, Pages 1798-1806

  Bouadma, Lila ^a,b,c   Sonneville, Romain ^c   Garrouste Orgeas, Maite ^a,d   Darmon, Michael ^e,f   Souweine, Bertrand ^g   Voiriot, Guillaume ^b,c   Kallel, Hatem ^h   Schwebel, Carole ⁱ   Goldgran Toledano, Dany ^j   Dumenil, Anne Sylvie ^k   Argaud, Laurent ^l   Ruckly, Stephane ^m   Jamali, Samir ⁿ   Planquette, Benjamin ^o   Adrie, Christophe ^p   Lucet, Jean Christophe ^a,b,c   Azoulay, Elie ^b,q   Timsit, Jean François ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BICHAT HOSPITAL   (France)

^d SAINT JOSEPH HOSPITAL   (France)

^e UNIVERSITÉ JEAN MONNET   (France)

^f UNIVERSITÉ JEAN MONNET   (France)

^g SERVICE DE RHUMATOLOGIE   (France)

^h Parasitology Mycology Laboratory   (France)

ⁱ GRENOBLE UNIVERSITY HOSPITAL   (France)

^j Gonesse General Hospital   (France)

^k HÔPITAL ANTOINE BÉCLÈRE   (France)

^l EDOUARD HERRIOT HOSPITAL   (France)

^m UNIV GRENOBLE ALPES   (France)

ⁿ Dourdan Hospital   (France)

^o CENTRE HOSPITALIER DE VERSAILLES   (France)

^p Saint Denis Regional hospital Center   (France)

^q SAINT LOUIS HOSPITAL   (France)

more..

Author keywords

Infection related ventilator associated complication; nosocomial infections; surveillance; ventilator associated condition; ventilator associated event; ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; DISEASE SURVEILLANCE; FEMALE; HOSPITAL INFECTION; HUMAN; INCIDENCE; LENGTH OF STAY; LIFE SUSTAINING TREATMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MECHANICAL VENTILATOR; MEDICAL DEVICE COMPLICATION; MORTALITY RATE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA; ADVERSE EFFECTS; AGE; APACHE; BODY MASS; CLINICAL TRIAL; CROSS INFECTION; GLASGOW COMA SCALE; INTENSIVE CARE UNIT; MIDDLE AGED; MULTICENTER STUDY; ORGAN DYSFUNCTION SCORE; PNEUMONIA, VENTILATOR-ASSOCIATED; RISK FACTOR; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; APACHE; BODY MASS INDEX; CROSS INFECTION; FEMALE; GLASGOW COMA SCALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; ORGAN DYSFUNCTION SCORES; PNEUMONIA, VENTILATOR-ASSOCIATED; PREVALENCE; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX FACTORS; UNITED STATES;

EID: 84943185142     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001091     Document Type: Article

References (24)

1. Bouadma L, Wolff M, Lucet JC: Ventilator-associat pneumonia and its prevention. Curr Opin Infect Dis 2012; 25:395-404
2. Zahar JR, Nguile-Makao M, Francąis A, et al: Pricting the risk of document ventilator-associat pneumonia for benchmarking: Construction and validation of a score. Crit Care M 2009; 37:2545-2551
3. Bouadma L, Deslandes E, Lolom I, et al: Long-term impact of a multifacet prevention program on ventilator-associat pneumonia in a mical intensive care unit. Clin Infect Dis 2010; 51:1115-1122
4. Horan TC, Andrus M, Dudeck MA: CDC/NHSN surveillance definition of health care-associat infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-332
5. Klompas M: Does this patient have ventilator-associat pneumonia? JAMA 2007; 297:1583-1593
6. Centers for Disease Control and Prevention: Ventilator-associat event protocol. Available at: http://www.cdc.gov/nhsn/acute-carehospital/vae/. Access April 16, 2014
7. Klompas M: Complications of mechanical ventilation-The CDC's new surveillance paradigm. N Engl J M 2013; 368:1472-1475
8. Klompas M, Khan Y, Kleinman K, et al; CDC Prevention Epicenters Program: Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation. PLoS One 2011; 6:e18062
9. Hayashi Y, Morisawa K, Klompas M, et al: Toward improv surveillance: The impact of ventilator-associat complications on length of stay and antibiotic use in patients in intensive care units. Clin Infect Dis 2013; 56:471-477
10. Muscere J, Sinuff T, Heyland DK, et al; Canadian Critical Care Trials Group: The clinical impact and preventability of ventilator-associat conditions in critically ill patients who are mechanically ventilat. Chest 2013; 144:1453-1460
11. Prospero E, Illuminati D, Marigliano A, et al: Learning from Galileo: Ventilator-associat pneumonia surveillance. Am J Respir Crit Care M 2012; 186:1308-1309
12. Klein Klouwenberg PM, van Mourik MS, Ong DS, et al; MARS Consortium: Electronic implementation of a novel surveillance paradigm for ventilator-associat events. Feasibility and validation. Am J Respir Crit Care M 2014; 189:947-955
13. Garrouste Orgeas M, Timsit JF, Soufir L, et al; OUTCOMEREA Study Group: Impact of adverse events on outcomes in intensive care unit patients. Crit Care M 2008; 36:2041-2047
14. Garrouste-Orgeas M, Timsit JF, Vesin A, et al; OUTCOMEREA Study Group: Select mical errors in the intensive care unit: Results of the IATROREF study: Parts I and II. Am J Respir Crit Care M 2010; 181:134-142
15. Promotion et development de la recherche et de l'enseignement en reánimation [in French]. Available at: http://www.outcomerea.org/. Access April 16, 2014
16. Azoulay E, Garrouste M, Goldgran-Tolano D, et al: Increas nonbeneficial care in patients spending their birthday in the ICU. Intensive Care M 2012; 38:1169-1176
17. Planquette B, Timsit JF, Misset BY, et al; OUTCOMEREA Study Group: Pseudomonas aeruginosa ventilator-associat pneumonia. Prictive factors of treatment failure. Am J Respir Crit Care M 2013; 188:69-76
18. Bekaert M, Timsit JF, Vansteelandt S, et al; Outcomerea Study Group: Attributable mortality of ventilator-associat pneumonia: A reappraisal using causal analysis. Am J Respir Crit Care M 2011; 184:1133-1139
19. Donchin Y, Gopher D, Olin M, et al: A look into the nature and causes of human errors in the intensive care unit. Crit Care M 1995; 23:294-300
20. Klompas M, Magill S, Robicsek A, et al; CDC Prevention Epicenters Program: Objective surveillance definitions for ventilator-associat pneumonia. Crit Care M 2012; 40:3154-3161
21. An approach to the evaluation of quality indicators of the outcome of care in hospitaliz patients, with a focus on nosocomial infection indicators. The Quality Indicator Study Group. Am J Infect Control 1995; 23:215-222
22. Lee GM, Kleinman K, Soumerai SB, et al: Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J M 2012; 367:1428-1437
23. Rothschild JM, Landrigan CP, Cronin JW, et al: The Critical Care Safety Study: The incidence and nature of adverse events and serious mical errors in intensive care. Crit Care M 2005; 33:1694-1700
24. Harbarth S, Sax H, Gastmeier P: The preventable proportion of nosocomial infections: An overview of publish reports. J Hosp Infect 2003; 54:258-266; quiz 321